Skip to main content
Clinical Trials/CTRI/2020/07/026840
CTRI/2020/07/026840
Completed
未知

A Prospective Randomized Controlled Clinical Trial to evaluate the Efficacy and Safety of Guduchi Ghan Vati in the management of COVID-19 infection.

Directorate of AYUSH Government of Madhya Pradesh0 sites30 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Directorate of AYUSH Government of Madhya Pradesh
Enrollment
30
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
September 11, 2020
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Directorate of AYUSH Government of Madhya Pradesh

Eligibility Criteria

Inclusion Criteria

  • Mild to moderate cases registered in the Hospital,
  • above 18 years of age, with COVID 2019 (Confirmed by
  • RT\-PCR) quarantined at identified hospital set up.
  • Participants who can take medicines orally.
  • Patients willing to provide signed informed consent.

Exclusion Criteria

  • Cases of severe vomiting which would make oral administration of medicine difficult.
  • Cases of respiratory failure and requiring mechanical ventilation.
  • Alanine Transaminase (ALT) or Aspartate Transaminase (AST) \> 2 times the upper limit of normal.
  • Patients with COVID 19 in critical condition or ARDS or NIAD 8 â??point ordinal score 2 Hospitalized, on invasive mechanical Ventilation or extra corporeal membrane oxygenation
  • Pregnant or lactating women
  • Any other condition, which as per the investigator would jeopardize the outcome of the trial.
  • Withdrawal Criteria:
  • a) The participant may be withdrawn from the trial if there is
  • Any major ailment which necessitating the institution of new modalities of treatment.
  • Non\-compliance of the treatment regimen (minimum 80% compliance is essential to continue in the study).

Outcomes

Primary Outcomes

Not specified

Similar Trials